49 results about "Hematocrit levels" patented technology

The present invention is directed towards apparatuses and methods for the automated measurement of blood analytes and blood parameters for bedside monitoring of patient blood chemistry. Particularly, the current invention discloses a programmable system that can automatically draw blood samples at a suitable programmable time frequency (or at predetermined timing), can automatically analyze the drawn blood samples and immediately measure and display blood parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or any other blood parameter.

There is provided the reagent layer composition that can substantially reduce the measurement bias arising from hematocrits. The addition of fatty acid (4-20 carbons) and quaternary ammonium salt to a commonly used reagent layer composition composed of an enzyme, an electron transfer mediator, and several water soluble polymers not only reduce the hematocrit level-dependent bias but also provide very stable performance for an extended period of time. Disclosed are also various types of sub microliter sample volume electrochemical biosensors that are suitable to use with the reagent layer composition of present invention.

The present invention is related to an electrochemical biosensing test strip, biosensing meter, system and method for analyte measurement incorporating a hematocrit correction. The biosensor strip comprises a first and a second electrode sets respectively for detecting analyte concentration and hematocrit level. The first and second electrode sets are respectively corresponding to different reaction zones and a reaction reagent is only formed on the first electrode set corresponding reaction zone. Applying a first signal comprising a DC component and a second signal comprising an AC component that has a constant frequency respectively to the first and second electrode sets can respectively detect an uncorrected analyte concentration and hematocrit level. Therefore, the corrected analyte concentration is more accurate by incorporating the hematocrit correction.

The present invention provides a reference solution for use in instruments that determine hematocrit levels in biological samples by measuring the resistance and/or conductivity of the biological samples. A reference solution according to the invention achieves conductivities representative of known hematocrit levels in blood, while maintaining tolerable levels of interference with the measurement of other analytes in the reference solution.

In a method for detecting a change of a condition of a patient using an implantable medical device being connectable to the patient in at least one electrode configuration, at least one impedance measurement session is initiated to obtain at least one impedance value corresponding to an impedance of whole blood of the patient. At least one relative or absolute value of an amount of hematocrit in the blood of the patient is calculated using the at least one impedance value. A present hematocrit level is determined dependent on the at least one hematocrit value, with a change of the condition being derived from the present hematocrit level of the patient.

The present invention provides a biosensor capable of measuring various blood components, in particular, the concentration of blood glucose with high accuracy even when a hematocrit level varies. The above-described object was achieved by a biosensor 10, which includes an electrically insulating substrate 102, an electrode system 104 including a working electrode 1042 and a counter electrode 1044 formed on the electrically insulating substrate 102, and a reagent layer 204 containing an oxidoreductase and a redox mediator, and in which the electrode system 104 is formed from gold, a hydrophilic polymer layer 202 is provided on the electrode system 104, and the reagent layer 204 is provided outside the hydrophilic polymer layer 202 so that the oxidoreductase and the redox mediator are transferred to the hydrophilic polymer layer 202 after coming into contact with a sample.

The present invention provides an electrochemical method and a test strip for detecting hemoglobin in a specimen. The method includes the steps of providing the specimen with a reagent, which has a buffer solution, a surfactant and an electron mediator, tetrathiafulvalene, modified by cyclodextrin; detecting electric current produced by the reaction of the hemoglobin and the electron mediator in a specimen under a potentiostatic condition; and calculating a hemoglobin concentration in the specimen according to the detected electric current. In the method of the present invention, tetrathiafulvalene modified by cyclodextrin is used as an electron mediator, which directly interacts with the hemoglobin in the specimen. Since the hemoglobin concentration is in inverse proportion to the value of electric current or the value of SOC (state-of-charge) integrated by electric current value with time, the hemoglobin concentration in a whole blood specimen or the hematocrit level in a blood specimen is accurately and rapidly obtained according to the detected electric value or the value of SOC.

The invention provides a detection method, which is used for detecting blood glucose level and hemoglobin level used for detecting a blood sample. The method comprises the following steps: applying first voltage on the blood sample, taking a first blood sugar level; applying second voltage on the blood sample, taking a second blood sugar level; applying third voltage on the blood sample, collecting a hematocrit index and a hemoglobin index; transferring the hematocrit index to the hematocrit level, correcting the second blood sugar level by the hematocrit level; and transferring the hemoglobin index to the hemoglobin level. The method can be used for simultaneously detecting the blood glucose level and hemoglobin level used for detecting the blood sample on a single detector by using a single test piece.

A hemolysis detection method and system includes measuring a conductance of a blood sample in a sample test module at a plurality of multiple-frequency AC inputs provided by a sine-wave generator module, calculating an immittance value for each of the plurality of multiple-frequency AC inputs received from a multichannel A/D converter module using a computer processing module, and subjecting each immittance value calculated to a function that maps immittance values to either lysed blood levels or hematocrit levels residing in the processing module and applying further processing residing in a memory module to produce respective percent-lysed value or hematocrit value of the blood sample.